Prognostic value of early normalization of CA 125 during the induction chemotherapy in stages III and IV ovarian carcinoma;Valeur pronostique de la normalisation precoce du CA 125 au cours de la chimiotherapie des tumeurs de l'ovaire stades III et IV

Bulletin du Cancer

Volumn 84, Issue 7, 1997, Pages 722-728

  Ferrero, Jean Marc ^a   Largillier, Rémj ^a   Ramaioli, Alain ^a   Heudier, Philippe ^a   Teissier, Eric ^a   Namer, Moïse ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

CA 125; Ovarian carcinorna; Prognosis

Indexed keywords

CA 125 ANTIGEN;

ADULT; ANALYTIC METHOD; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOSENSITIVITY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TIME FACTORS;

EID: 0030742698     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rezvani A, Lê MG. Évolution de la mortalité par cancer de l'ovaire en France entre 1968 et 1991. Bull Cancer 1994 ; 81 : 1091-5.
2. Cannistra SA. Cancer of the ovary. Review article. N Engl J Med 1993 ; 329 (21) : 1550-9.
3. Van Der Burg MEL, Van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995 ; 10 : 629-34.
4. National institute of Health. Consensus development conference statement. Ovarian cancer : screening, treatment, and follow-up. Washington, April 5-7, 1994.
5. Markman M. CA 125 : an evolving role in the management of ovarian cancer. J Clin Oncol 1996 ; 14 : 1411-2.
6. Cruickshank DJ, Paul J, Lewis CR, McAllister EJ, Kaye SB. An independent evaluation of the potential clinical usefulness of proposed CA 125 indices previously shown to be of pronostic significance in epithelial ovarian cancer. Br J Cancer 1992 ; 65 : 597-600.
7. Riedinger JM, Barillot I, Coudert B, Fargeot P, Berriolo- Riedinger A, Guerrin J. Valeur pronostique de la demi-vie initiale du CA 125 mesurée au cours de la chimiothérapie d'induction chez 62 patientes porteuses de tumeur épithéliale ovarienne stade III ou IV. Bull Cancer 1996 ; 83 : 654-63.
8. Rustin GJS, Nelstrop AE, McClean P, Brady MF, McGuire WP, Hoskin WJ, Mitchell H, Lambert HE. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol 1996 ; 14 : 1545-51.
9. Liu PY, Alberts DS, Federico M, et al. CA125 concentration 8 weeks after treatment initiation independently predicts survival in patients with advanced epithelial ovarian cancer: a Southwest Oncology Group (SWOG) study. Proc Am Soc Clin Oncol 1995 ; 14 : 266 (abstr.).
10. Lavin PT, Knapp RC, Malkassion G, Withney CW, Berek JC, Bast RC. CA 125 for monitoring ovarian carcinoma during primary therapy. Obstet Gynecol 1987 ; 69 : 223-7.
11. Buller RE, Berman ML, Bloss JD, Manetta A, Di Saia PJ. CA 125 regression: a model for epithelial ovarian cancer response. Am J Obstet Gynecol 1991 ; 165 : 360-7.
12. Yedema CA, Kenemans P, Voorhorst F, Bon G, Schijf C, Beex L, Verstraeten A, Hilgers J, Vermorken J. CA 125 half-life in ovarian cancer: a multivariate survival analysis. Br J Cancer 1993 ; 67 : 1361-7.
13. Rubin SC, Hoskin WJ, Hakes TB, et al. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol 1989 ; 160 : 667-71.
14. Chevalier B, Dessogne P. Cancer epithelial de l'ovaire, quel consensus en 1995 ? Bull Cancer 1995 ; 82 : 923-8.
15. Bast RC, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983 ; 309 : 883-7.